Abstract:【Objective】 To analyze the clinical characteristics and 25-hydroxyvitamin D3[25(OH)D3] levels of infants and young children with rickets in the urban area of Baoji City. 【Methods】 A total of 274 infants and young children who underwent routine health management at children's health clinics in various communities in the urban area of Baoji City from January 2020 to December 2020 were selected as the research objects. Basic information such as age,gender,height,weight,and dietary habits was recorded during the routine physical examination. The prevalence of rickets was analyzed based on imaging results. The clinical characteristics and levels of 25(OH)D3 and bone alkaline phosphatase (BALP) were compared between infants and young children with and without rickets. The value of 25(OH)D3 and BALP levels in predicting rickets in infants and young children was evaluated through ROC analysis. 【Results】 The incidence of rickets in infants aged 0 to 6 months was significantly higher than that in other age groups (P<0.05),while there was no significant difference in incidence among other age groups (P>0.05). Clinical characteristics such as increased sweating,diarrhea,abnormal or delayed bone development,motor dysfunction,and joint pain were more common in the rickets group than in the non-rickets group (P<0.05). The 25(OH)D3 level was lower and the BALP level was higher in the rickets group than in the non-rickets group (P<0.05). The ROC analysis confirmed that the 25(OH)D3 and BALP levels can be used to predict rickets in infants and young children with AUC values of 0.958 and 0.990,respectively,(both with P<0.05). 【Conclusion】 Infants aged 0 to 6 months are a high-risk age group for rickets,with clinical features mainly including increased sweating,diarrhea,abnormal or delayed bone development,motor dysfunction. In addition,the 25(OH)D3 level is lower in this group. Clinically,it is recommended to focus on screening children with the above risk factors and provide effective preventive and therapeutic measures as early as possible.
柳文婧, 吕菊红, 李冬梅, 吴宁, 陈银银, 颜靖棠. 宝鸡市城区婴幼儿佝偻病患儿的临床特征及血清25(OH)D3水平分析[J]. 医学临床研究, 2023, 40(4): 571-574.
LIU Wen-jing, LYU Ju-hong, LI Dong-mei, et al. Investigation and Analysis of Clinical Characteristics and 25(OH)D3 Levels of Infants and Young Children with Rickets in Urban Area of Baoji City. JOURNAL OF CLINICAL RESEARCH, 2023, 40(4): 571-574.
[1] 李永犇,尹帅,赵彬.维生素D缺乏性佝偻病患者血清PTH、VDBP表达水平及相关性分析[J].四川医学,2022,43(10):1018-1022. [2] 夏永杰,韩镜明,游超,等. 血清骨代谢生化指标对儿童维生素D缺乏性佝偻病的诊断价值探讨[J].重庆医学,2020,49(20):3392-3394. [3] 赵明远,武希润,李红霞,等. 血清25羟维生素D3的水平与肝硬化食管静脉曲张破裂出血的相关性[J].中华肝脏病杂志,2019,27(5):358-362. [4] 毛萌,江帆. 儿童保健学[M].4版.北京:人民卫生出版社,2020:26-29. [5] 黎海芪,毛萌. 中国儿童维生素D缺乏性佝偻病诊治变迁[J].中华儿科杂志,2022,60(5):377-379. [6] 朱琳,马静,李晓丹,等. 我国低磷性佝偻病患者生存状况调查分析[J].中国卫生经济,2022,41(6):67-71. [7] 俞琳,陈萍,洪开听,等. 超声骨密度检测对婴幼儿维生素D缺乏性佝偻病的早期诊断效能[J].中国妇幼保健,2021,36(24):5838-5840. [8] 邵洁. 儿童维生素D、钙营养与营养性维生素D缺乏性佝偻病判定与评价现状[J].中国实用儿科杂志,2012,27(3):161-165. [9] 刘小莉,张红梅,张静,等. 脊柱关节炎患者血清中25-(OH)D3、t-PINP、b-CTx水平表达及临床相关性研究[J].现代检验医学杂志,2020,35(3):26-30. [10] 张会丰,余晓丹,毛萌,等. 中国儿童维生素D营养相关临床问题实践指南解读[J].中华儿科杂志,2022,60(5):408-412. [11] OLIVIA F,ALEXANDRA W B,KLARA M,et al.Hypovitaminosis D in migrant children in Switzerland:a retrospective study[J].Eur J Pediatr,2021,180(8):2637-2644. [12] 李文娟.小儿维生素D缺乏与身高发育偏离的相关性[J].中国药物与临床,2021,21(7):1130-1132. [13] 王翠翠,谢坤霞,王宽峰.磷酸盐合剂联合维生素D3对营养性佝偻病患儿血清25-羟维生素D粒细胞集落刺激因子及肿瘤坏死因子-α水平的影响[J].中国妇幼保健,2021,36(5):1053-1056. [14] TOM D T,CHRISTOPHER T S,RAMON A D A,et al. The Validity of serum alkaline phosphatase to identify nutritional rickets in nigerian children on a calcium-deprived diet[J].J Clin Endocrinol Metab,2021,106(9):3559-3564.